by S. Christian Platt | Aug 2, 2018 | PTAB News, PTAB Trial Basics
By: S. Christian Platt and Michael Lavine On July 26, 2018, the Silicon Valley Regional Office of the United States Patent and Trademark Office (“USPTO”) hosted a Judicial Conference by the Patent Trial and Appeal Board (“PTAB”). During the conference, a panel of...
by Gasper LaRosa | Jul 30, 2018 | PTAB News
By: Gasper J. LaRosa Last week, Chief Judge Ruschke made the attached presentation to the International Intellectual Property Association. Chief Judge Ruschke emphasized that IPR filings appear to be leveling off and that the PTAB does not invalidate patents at a...
by Marc S. Blackman | Jul 26, 2018 | Federal Circuit Appeal, PTAB News
By: Marc S. Blackman, Lisa L. Furby, and John Normile The Federal Circuit, in a matter of first impression, has ruled that tribal sovereign immunity does not apply to inter partes review (“IPR”) proceedings. Allergan, the maker of Restasis, a chronic...
by Matthew Johnson | Jul 11, 2018 | PTAB News
By: Rich Graham and Matt Johnson On July 10, 2018, the PTAB announced the designation the following five decisions as informative: Colas Sols. Inc. v. Blacklidge Emulsions, Inc., Case IPR2018-00242, Paper 9 (Feb. 27, 2018) – holding that 35 U.S.C. § 315(a)(1) bars...
by Carl Kukkonen | Jun 21, 2018 | PTAB News
By: Carl A. Kukkonen and Matt Johnson Last week, the United States Patent and Trademark Office (USPTO) hosted the annual meeting of the heads of the world’s five largest intellectual property offices, commonly referred to as the IP5 (see a related press release). In...
by Greg Castanias | Jun 18, 2018 | PTAB News
By: Greg Castanias, David Cochran, and John Marlott On April 24, 2018, in SAS Institute Inc. v. Iancu, a closely divided U.S. Supreme Court fundamentally changed the way that the Patent Trial and Appeal Board confronts inter partes reviews under the America Invents...
